STREPTOCOCCUS-PNEUMONIAE POLYSACCHARIDE VACCINE - AGE AND DOSE RESPONSES, SAFETY, PERSISTENCE OF ANTIBODY, RE-VACCINATION, AND SIMULTANEOUS ADMINISTRATION OF PNEUMOCOCCAL AND INFLUENZA VACCINES

被引：0
|
作者：
HILLEMAN, MR
CARLSON, AJ
MCLEAN, AA
VELLA, PP
WEIBEL, RE
WOODHOUR, AF
机构：
[1] CHILDRENS HOSP,PHILADELPHIA,PA 19104
[2] UNIV PENN,SCH MED,DEPT PEDIAT,PHILADELPHIA,PA 19104
来源：
REVIEWS OF INFECTIOUS DISEASES | 1981年 / 3卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：S31 / S42
页数：12
相关论文
共 15 条
  • [1] DOES VACCINATION WITH PNEUMOCOCCAL POLYSACCHARIDE GENERATE EFFECTIVE OPSONIZING ANTIBODY AGAINST STREPTOCOCCUS-PNEUMONIAE
    MUSHER, D
    CHAPMAN, A
    GOREE, A
    JONSSON, S
    BAUGHN, R
    [J]. CLINICAL RESEARCH, 1986, 34 (01): : A222 - A222
  • [2] Immunogenicity and Persistence of a Prime-Boost Re-Vaccination Strategy for Pneumococcal Vaccines (13-Valent Pneumococcal Conjugate Vaccine+23-Valent Pneumococcal Polysaccharide Vaccine) in Patients with Rheumatoid Arthritis: A Pilot Study
    Bahuaud, Mathilde
    Beaudouin, Constance
    Molto, Anna
    Launay, Odile
    Batteux, Frederic
    Dougados, Maxime
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [3] ANTIBODY TO CAPSULAR POLYSACCHARIDES OF STREPTOCOCCUS-PNEUMONIAE AFTER VACCINATION OF HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED SUBJECTS WITH 23-VALENT PNEUMOCOCCAL VACCINE
    RODRIGUEZBARRADAS, MC
    MUSHER, DM
    LAHART, C
    LACKE, C
    GROOVER, J
    WATSON, D
    BAUGHN, R
    CATE, T
    CROFOOT, G
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1992, 165 (03): : 553 - 556
  • [4] Lower Immunoglobulin G Antibody Responses to Pneumococcal Conjugate Vaccination at the Age of 2 Years after Previous Nasopharyngeal Carriage of Streptococcus pneumoniae
    Rodenburg, Gerwin D.
    van Gils, Elske J. M.
    Veenhoven, Reinier H.
    Bogaert, Debby
    van den Dobbelsteen, Germie P. J. M.
    Berbers, Guy A. M.
    Sanders, Elisabeth A. M.
    [J]. JOURNAL OF PEDIATRICS, 2011, 159 (06): : 965 - U127
  • [5] Safety and Antibody Response, Including Antibody Persistence for 5 Years, after Primary Vaccination or Revaccination with Pneumococcal Polysaccharide Vaccine in Middle-Aged and Older Adults
    Musher, Daniel M.
    Manoff, Susan B.
    Liss, Charlie
    McFetridge, Richard D.
    Marchese, Rocio D.
    Bushnell, Bonnie
    Alvarez, Frances
    Painter, Carla
    Blum, Michael D.
    Silber, Jeffrey L.
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2010, 201 (04): : 516 - 524
  • [6] Evaluation of antibody titer against streptococcus pneumoniae capsular polysaccharide after vaccination in children with chronic renal failure (CRF) with 7-valent conjugated pneumococcal vaccine
    Vieira, S.
    Koch, V. H. K.
    Baldacci, E. R.
    [J]. PEDIATRIC NEPHROLOGY, 2007, 22 (12) : 2153 - 2153
  • [7] Safety and antibody persistence following Haemophilus influenzae type b conjugate or pneumococcal polysaccharide vaccines given before pregnancy in women of childbearing age and their infants
    Santosham, M
    Englund, JA
    McInnes, P
    Croll, J
    Thompson, CM
    Croll, L
    Glezen, WP
    Siber, GR
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2001, 20 (10) : 931 - 940
  • [8] Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children
    Levin, Myron J.
    Song, Lin-Ye
    Fenton, Terrence
    Nachman, Sharon
    Patterson, Julie
    Walker, Robert
    Kemble, George
    Allende, Maria
    Hultquist, Micki
    Yi, Tingting
    Nowak, Barbara
    Weinberg, Adriana
    [J]. VACCINE, 2008, 26 (33) : 4210 - 4217
  • [9] Immunogenicity, Safety and Antibody Persistence of a Booster Dose of Quadrivalent Meningococcal ACWY-tetanus Toxoid Conjugate Vaccine Compared with Monovalent Meningococcal Serogroup C Vaccine Administered Four Years After Primary Vaccination Using the Same Vaccines
    Vesikari, Timo
    Forsten, Aino
    Bianco, Veronique
    Van der Wielen, Marie
    Miller, Jacqueline M.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2015, 34 (12) : E298 - E307
  • [10] Immunogenicity and safety of an inactivated quadrivalent influenza vaccine co-administered with a 23-valent pneumococcal polysaccharide vaccine versus separate administration, in adults ≥50 years of age: Results from a phase III, randomized, non-inferiority trial
    Ofori-Anyinam, Opokua
    Leroux-Roels, Geert
    Drame, Mamadou
    Aerssens, Annelies
    Maes, Cathy
    Amanullah, Arshad
    Schuind, Anne
    Li, Ping
    Jain, Varsha K.
    Innis, Bruce L.
    [J]. VACCINE, 2017, 35 (46) : 6321 - 6328
12